| Nanotechnology in pulmonary medicine M Doroudian, A O’Neill, R Mac Loughlin, A Prina-Mello, Y Volkov, ... Current opinion in pharmacology 56, 85-92, 2021 | 57 | 2021 |
| The association between HPV gene expression, inflammatory agents and cellular genes involved in EMT in lung cancer tissue M Rezaei, S Mostafaei, A Aghaei, N Hosseini, H Darabi, M Nouri, ... BMC cancer 20, 1-11, 2020 | 28 | 2020 |
| Applications of iron oxide nanoparticles against breast cancer H Hosseinkazemi, S Samani, A O’Neill, M Soezi, M Moghoofei, ... Journal of Nanomaterials 2022, 1-12, 2022 | 24 | 2022 |
| Aerosolized Drug-Loaded Nanoparticles Targeting Migration Inhibitory Factors Inhibit Pseudomonas Aeruginosa-Induced Inflammation and Biofilm Formation M Doroudian, A O’Neill, C O’Reilly, A Tynan, L Mawhinney, A McElroy, ... Nanomedicine 15 (30), 2933-2953, 2020 | 24 | 2020 |
| Lipid Nanoparticles as Promising Carriers for mRNA Vaccines for Viral Lung Infections M Hajiaghapour Asr, F Dayani, F Saedi Segherloo, A Kamedi, AO Neill, ... Pharmaceutics 15 (4), 1127, 2023 | 20 | 2023 |
| Nanocarriers: A novel strategy for the delivery of CRISPR/Cas systems F Hejabi, MS Abbaszadeh, S Taji, A O’Neill, F Farjadian, M Doroudian Frontiers in Chemistry 10, 957572, 2022 | 14 | 2022 |
| Candidate role for Toll-like receptor 3 L412F polymorphism and infection in acute exacerbation of idiopathic pulmonary fibrosis AN McElroy, R Invernizzi, JW Laskowska, A O’Neill, M Doroudian, ... American journal of respiratory and critical care medicine 205 (5), 550-562, 2022 | 14 | 2022 |
| The role of Epstein‐Barr virus‐expressed genes in breast cancer development. S Mostafaei, P Vahidi Manesh, J Sadri Nahand, A Nesaei, S Sorayyayi, ... Breast Journal 26 (11), 2020 | 9 | 2020 |
| Macrophage migration inhibitory factor enhances Pseudomonas aeruginosa biofilms, a potential novel therapeutic for cystic fibrosis patients A O'Neill, A Tynan, L Mawhinney, S Kennedy, E Caraher, FE Poynton, ... IRISH JOURNAL OF MEDICAL SCIENCE 186 (SUPPL 10), S420-S421, 2017 | 1 | 2017 |
| Aerosolized nanodrug delivery system to inhibit Macrophage migration inhibitory factor in order to treat lung cancer M Doroudian, FE Poynton, C O'Reilly, K Crosbie-Staunton, ... Medicine 20 (1), 729-35, 2014 | 1 | 2014 |
| Toll-like Receptor 3 Leu412Phe: A Candidate Polymorphism in Lung Microbiome Dysregulation and Acute Exacerbation in Idiopathic Pulmonary Fibrosis Patients ME Armstrong, AN McElroy, R Invernizzi, JW Laskowska, A O'Neill, ... B107. GENETIC AND TRANSCRIPTOMIC SIGNATURES IN LUNG DISEASES, A4889-A4889, 2024 | | 2024 |
| Candidate role for Toll-like receptor 3 L412F polymorphism in bacterial infection and acute exacerbation in idiopathic pulmonary fibrosis AN McElroy, R Invernizzi, JW Laskowska, A O'Neill, M Doroudian, ... IRISH JOURNAL OF MEDICAL SCIENCE 190 (SUPPL 5), 209-209, 2021 | | 2021 |
| Characterisation of the efficacy of two novel host-directed therapies, SCD-19 and 4-octyl itaconate, in the treatment of Pseudomonas aeruginosa infection in cystic fibrosis. A O’Neill Trinity College Dublin, 2021 | | 2021 |
| Toll-like receptor 3 (TLR3) L412F as a candidate biomarker in Idiopathic Pulmonary Fibrosis (IPF) and its role in antibacterial and antiviral responses. AN McElroy, DN O'Dwyer, G Cooke, L Mawhinney, A Tynan, M Doroudian, ... IRISH JOURNAL OF MEDICAL SCIENCE 186 (SUPPL 10), S404-S404, 2017 | | 2017 |
| Characterisation of the effect of interleukin-17A (IL-17A) on Toll-like receptor 3 (TLR3) function in Idiopathic Pulmonary Fibrosis (IPF): a candidate novel mechanism for … L Bergin, AN McElroy, G Cooke, L Mawhinney, A Tynan, M Doroudian, ... IRISH JOURNAL OF MEDICAL SCIENCE 186 (SUPPL 10), S422-S422, 2017 | | 2017 |
